The total return over the past 12 months is -83.19% vs. +16.94% for the S&P 500. So far it's up -51.85% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (83.43%) | (78.94%) | (78.34%) | (65.80%) | (51.08%) | (44.15%) |
| Total Return CAGR | (83.19%) | (78.83%) | (78.27%) | (65.74%) | (51.03%) | (44.11%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Aethlon Medical, Inc. (AEMD)
| Year | Start price | End price | AEMD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $13.85 | $6.53 | (51.85%) | +14.51% | (66.36%) |
| 2025 | $344.00 | $13.85 | (96.00%) | +17.72% | (113.72%) |
| 2024 | $876.00 | $344.00 | (60.73%) | +24.89% | (85.62%) |
| 2023 | $1,101.60 | $876.00 | (20.49%) | +26.19% | (46.68%) |
| 2022 | $7,440.00 | $1,101.60 | (85.19%) | (18.17%) | (67.02%) |
| 2021 | $9,880.00 | $7,440.00 | (24.70%) | +28.74% | (53.44%) |
| 2020 | $3,852.00 | $9,880.00 | +156.49% | +18.37% | +138.12% |
| 2019 | $99,600.00 | $3,852.00 | (96.13%) | +31.22% | (127.35%) |
| 2018 | $67,800.00 | $99,600.00 | +46.90% | (4.56%) | +51.46% |
| 2017 | $252,000.00 | $67,800.00 | (73.10%) | +21.70% | (94.80%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
